The FDA lifted its clinical hold on Novavax's COVID-flu vaccine trial. The hold was due to unrelated safety concerns, allowing trial resumption. Novavax aims for growth with its combination shot ...

Novavax is already poised to benefit from a separate combined Covid-flu vaccine ... combined shot. Meanwhile, Moderna said last week that it plans to file for FDA approval of its own combo vaccine ...

Novavax (NVAX) announced that the U.S. FDA has removed the clinical hold on Novavax’s Investigational New Drug application for its COVID-19-Influenza Combination and stand-alone influenza ...

The lifted hold applies to Novavax’s flu ... combo vaccine. A trial participant who’d received the shot in Jan. 2023 later developed motor neuropathy, or muscle weakness, leading the FDA ...

Investing.com -- The U.S. Food and Drug Administration (FDA) has lifted its hold on a late-stage trial for Novavax’s COVID-influenza combination and standalone flu vaccines, the company reported on ...

The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu vaccines after a safety concern was found to be unrelated ...

Novavax (NASDAQ:NVAX) shares climbed 12% premarket on Monday after the U.S. FDA lifted clinical hold on the investigational new drug application for the pharma firm’s COVID-19-Influenza ...

(Reuters) -The U.S ... hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu vaccines after a safety ...

The US Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu ... shot, the company said. "The information provided to ...